PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-97.19%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-15.10%
Negative gross profit growth while MAXN is at 56.85%. Joel Greenblatt would examine cost competitiveness or demand decline.
65.81%
EBIT growth above 1.5x MAXN's 17.51%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
53.01%
Operating income growth above 1.5x MAXN's 17.51%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
65.32%
Net income growth 1.25-1.5x MAXN's 56.99%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
71.83%
EPS growth 1.25-1.5x MAXN's 53.91%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
71.83%
Diluted EPS growth 1.25-1.5x MAXN's 53.91%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-71.98%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-72.01%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
82.45%
OCF growth above 1.5x MAXN's 4.17%. David Dodd would confirm a clear edge in underlying cash generation.
85.98%
Positive FCF growth while MAXN is negative. John Neff would see a strong competitive edge in net cash generation.
-96.39%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-91.67%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-88.57%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-124.40%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
90.42%
Positive OCF/share growth while MAXN is negative. John Neff might see a comparative advantage in operational cash viability.
57.28%
3Y OCF/share CAGR above 1.5x MAXN's 3.29%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-136.70%
Negative 10Y net income/share CAGR while MAXN is at 34.24%. Joel Greenblatt sees a major red flag in long-term profit erosion.
69.14%
5Y net income/share CAGR above 1.5x MAXN's 34.24%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
30.87%
Positive short-term CAGR while MAXN is negative. John Neff would see a clear advantage in near-term profit trajectory.
-118.50%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
14.22%
Positive 5Y equity/share CAGR while MAXN is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-182.52%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.27%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-98.94%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-96.97%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-199.02%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-81.21%
We’re deleveraging while MAXN stands at 1.79%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-47.57%
We cut SG&A while MAXN invests at 23.70%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.